{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:53:27Z","timestamp":1794268407737,"version":"4.9.0"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s40121-022-00606-y","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T14:03:00Z","timestamp":1646143380000},"page":"713-742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":152,"title":["Coccidioidomycosis: A Contemporary Review"],"prefix":"10.1007","volume":"11","author":[{"given":"Nancy F.","family":"Crum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"606_CR1","first-page":"585","volume":"15","author":"A Posadas","year":"1892","unstructured":"Posadas A. Un nuevo caso de micosis fungoidea con posrospemias. An Cir Med Argent. 1892;15:585\u201397.","journal-title":"An Cir Med Argent"},{"key":"606_CR2","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1086\/513202","volume":"44","author":"JV Hirschmann","year":"2007","unstructured":"Hirschmann JV. The early history of coccidioidomycosis: 1892\u20131945. Clin Infect Dis. 2007;44:1202\u20137.","journal-title":"Clin Infect Dis"},{"key":"606_CR3","first-page":"209","volume":"10","author":"E Rixford","year":"1896","unstructured":"Rixford E, Gilchrist TC. Two cases of protozoan (coccidioidal) infection of the skin and other organs. Johns Hopkins Hosp Rep. 1896;10:209\u201368.","journal-title":"Johns Hopkins Hosp Rep"},{"key":"606_CR4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1084\/jem.6.4-6.443","volume":"6","author":"W Ophuls","year":"1905","unstructured":"Ophuls W. Further observations on a pathogenic mould formerly described as a protozoon (Coccidioides immitis, Coccidioides pyogenes). J Exp Med. 1905;6:443\u201385.","journal-title":"J Exp Med"},{"key":"606_CR5","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.2105\/AJPH.36.12.1394","volume":"36","author":"CE Smith","year":"1946","unstructured":"Smith CE, Beard RR. Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases. Am J Public Health Nations Health. 1946;36:1394\u2013402.","journal-title":"Am J Public Health Nations Health"},{"key":"606_CR6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0967772019896973","volume":"28","author":"JV Hirschmann","year":"2020","unstructured":"Hirschmann JV. Charles Edward Smith: Coccidioidomycologist and public health leader. J Med Biogr. 2020;28:24\u201330.","journal-title":"J Med Biogr"},{"key":"606_CR7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2307\/3761847","volume":"94","author":"MC Fisher","year":"2002","unstructured":"Fisher MC, Koenig GL, White TJ, Taylor JW. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia. 2002;94:73\u201384.","journal-title":"Mycologia."},{"key":"606_CR8","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1101\/gr.087551.108","volume":"19","author":"TJ Sharpton","year":"2009","unstructured":"Sharpton TJ, Rounsley SD, Gardner MJ, et al. Comparative genomic analyses of the human fungal pathogens Coccidioides and their relatives. Genome Res. 2009;19:1722\u201331.","journal-title":"Genome Res"},{"key":"606_CR9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.00005-13","volume":"26","author":"C Nguyen","year":"2013","unstructured":"Nguyen C, Barker BM, Hoover S, et al. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis. Clin Microbiol Rev. 2013;26:505\u201325.","journal-title":"Clin Microbiol Rev"},{"key":"606_CR10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/jof5030074","volume":"5","author":"PS Hamm","year":"2019","unstructured":"Hamm PS, Hutchison MI, Leonard P, Melman S, Natvig DO. First analysis of human Coccidioides isolates from New Mexico and the southwest Four Corners region: Implications for the distributions of C. posadasii and C. immitis and human groups at risk. J Fungi (Basel). 2019;5:74.","journal-title":"J Fungi (Basel)."},{"key":"606_CR11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1101\/gr.103911.109","volume":"20","author":"DE Neafsey","year":"2010","unstructured":"Neafsey DE, Barker BM, Sharpton TJ, et al. Population genomic sequencing of Coccidioides fungi reveals recent hybridization and transposon control. Genome Res. 2010;20:938\u201346.","journal-title":"Genome Res"},{"key":"606_CR12","doi-asserted-by":"crossref","first-page":"e0059821","DOI":"10.1128\/mSphere.00598-21","volume":"6","author":"NA Chow","year":"2021","unstructured":"Chow NA, Kangiser D, Gade L, et al. Factors influencing distribution of Coccidioides immitis in soil, Washington State 2016. mSphere. 2021;6:e0059821.","journal-title":"mSphere"},{"key":"606_CR13","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1080\/21505594.2018.1509667","volume":"9","author":"TN Kirkland","year":"2018","unstructured":"Kirkland TN, Fierer J. Coccidioides immitis and posadasii; a review of their biology, genomics, pathogenesis, and host immunity. Virulence. 2018;9:1426\u201335.","journal-title":"Virulence"},{"key":"606_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1196\/annals.1406.004","volume":"1111","author":"R Laniado-Laborin","year":"2007","unstructured":"Laniado-Laborin R. Expanding understanding of epidemiology of Coccidioidomycosis in the Western Hemisphere. Ann N Y Acad Sci. 2007;1111:19\u201334.","journal-title":"Ann N Y Acad Sci"},{"key":"606_CR15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/mmy\/myu004","volume":"52","author":"SM Johnson","year":"2014","unstructured":"Johnson SM, Carlson EL, Fisher FS, Pappagianis D. Demonstration of Coccidioides immitis and Coccidioides posadasii DNA in soil samples collected from Dinosaur National Monument. Utah Med Mycol. 2014;52:610\u20137.","journal-title":"Utah Med Mycol"},{"key":"606_CR16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1067\/mem.2002.123550","volume":"39","author":"P Perera","year":"2002","unstructured":"Perera P, Stone S. Coccidioidomycosis in workers at an archeologic site \u2013 Dinosaur National Monument, Utah, June\u2013July 20001. Ann Emerg Med. 2002;39:566\u20139.","journal-title":"Ann Emerg Med"},{"key":"606_CR17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/cid\/cis1028","volume":"56","author":"N Marsden-Haug","year":"2013","unstructured":"Marsden-Haug N, et al. Coccidioidomycosis acquired in Washington State. Clin Infect Dis. 2013;56:847\u201350.","journal-title":"Clin Infect Dis"},{"key":"606_CR18","unstructured":"Hawryluk M. Traces of Valley fever fungus found in central Oregon. The Bulletin [cited 2016 Jul 28].\u00a0http:\/\/www.bendbulletin.com\/home\/4524652-151\/traces-of-valley-fever-fungus-found-in-central. Accessed January 22, 2022."},{"key":"606_CR19","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3201\/eid2408.171595","volume":"24","author":"K Benedict","year":"2018","unstructured":"Benedict K, Ireland M, Weinberg MP, et al. Enhanced surveillance for coccidioidomycosis, 14 US States, 2016. Emerg Infect Dis. 2018;24:1444\u201352.","journal-title":"Emerg Infect Dis"},{"key":"606_CR20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/15572536.2006.11832638","volume":"98","author":"W Morrow","year":"2006","unstructured":"Morrow W. Holocene coccidioidomycosis: valley fever in early Holocene bison (Bison antiquus). Mycologia. 2006;98:669\u201377.","journal-title":"Mycologia"},{"key":"606_CR21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jim-2020-001655","volume":"69","author":"RH Johnson","year":"2021","unstructured":"Johnson RH, Sharma R, Kuran R, Fong I, Heidari A. Coccidioidomycosis: a review. J Investig Med. 2021;69:316\u201323.","journal-title":"J Investig Med"},{"key":"606_CR22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1086\/342409","volume":"186","author":"N Crum","year":"2002","unstructured":"Crum N, Lamb C, Utz G, et al. Coccidioidomycosis outbreak among United States Navy SEALs training in a Coccidioides immitis-endemic area\u2014Coalinga, California. J Infect Dis. 2002;186:865\u20138.","journal-title":"J Infect Dis"},{"key":"606_CR23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/mmy\/myy007","volume":"57","author":"JR Bowers","year":"2019","unstructured":"Bowers JR, Parise KL, Kelley EJ, et al. Direct detection of Coccidioides from Arizona soils using CocciENV, a highly sensitive and specific real-time PCR assay. Med Mycol. 2019;57:246\u201355.","journal-title":"Med Mycol"},{"key":"606_CR24","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/519937","volume":"45","author":"ME Gorris","year":"2007","unstructured":"Gorris ME, Caballero Van Dyke MC, Carey A. A Review of\u00a0Coccidioides\u00a0research, outstanding questions in the field, and contributions by women scientists. Clin Infect Dis. 2007;45:562\u20138.","journal-title":"Clin Infect Dis."},{"key":"606_CR25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s12879-016-1902-7","volume":"16","author":"M Del Rocio-Reyes-Montes","year":"2016","unstructured":"Del Rocio-Reyes-Montes M, Perez-Huitron MA, Ocana-Monroy JL, et al. The habitat of Coccidioides spp. and the role of animals as reservoirs in disseminators to nature. BMC Infect Dis. 2016;16:550\u20138.","journal-title":"BMC Infect Dis"},{"key":"606_CR26","first-page":"217","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC). Increase in reported coccidioidomycosis\u2014United States, 1998\u20132011. Morb Mortal Wkly Rep. 2013;62:217\u201321.","journal-title":"Morb Mortal Wkly Rep"},{"key":"606_CR27","unstructured":"Centers for Disease Control and Prevention. Valley fever (coccidiomycosis) statistics. 2020 [cited 2020 May 14]. https:\/\/www.cdc.gov\/fungal\/diseases\/coccidioidomycosis\/ statistics.html. Accessed January 20, 2022."},{"key":"606_CR28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.15585\/mmwr.mm6631a4","volume":"66","author":"GS Cooksey","year":"2017","unstructured":"Cooksey GS, Nguyen A, Knutson K, et al. Notes from the field: increase in coccidioidomycosis\u2014California, 2016. Morb Mortal Wkly Rep. 2017;66:833.","journal-title":"Morb Mortal Wkly Rep"},{"key":"606_CR29","unstructured":"California Department of Public Health. Epidemiological summary of coccidioidomycosis in California, 2018. https:\/\/www.cdph.ca.gov\/Programs\/CID\/DCDC\/Pages\/Coccidioidomycosis.aspxAccessed January 20, 2022."},{"key":"606_CR30","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.15585\/mmwr.mm6948a4","volume":"69","author":"GL Sondermeyer Cooksey","year":"2020","unstructured":"Sondermeyer Cooksey GL, Nguyen A, Vugia D, Jain S. Regional analysis of coccidioidomycosis incidence\u2014California, 2000\u20132018. Morb Mortal Wkly Rep. 2020;69:1817\u201321.","journal-title":"Morb Mortal Wkly Rep"},{"key":"606_CR31","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3389\/fimmu.2019.02188","volume":"10","author":"MC Caballero Van Dyke","year":"2019","unstructured":"Caballero Van Dyke MC, Thompson GR, Galgiani JN, Barker BM. The rise of\u00a0Coccidioides: forces against the dust devil unleashed. Front Immunol. 2019;10:2188.","journal-title":"Front Immunol"},{"key":"606_CR32","unstructured":"Gilford MA, Bus WC, Douds RJ. Annual report: Kern County Department of Public Health for the fiscal year July 1, 1936 to June 30, 1937. Kern County Department of Public Health. 1937. 47\u201352."},{"key":"606_CR33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1378\/chest.31.1.35","volume":"31","author":"PQ Edwards","year":"1957","unstructured":"Edwards PQ, Palmer CE. Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and to histoplasmin. Dis Chest. 1957;31:35\u201360.","journal-title":"Dis Chest"},{"key":"606_CR34","first-page":"178","volume":"15","author":"KT Maddy","year":"1958","unstructured":"Maddy KT. The geographic distribution of Coccidioides immitis and possible ecologic implications. Ariz Med. 1958;15:178\u201388.","journal-title":"Ariz Med"},{"key":"606_CR35","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2105\/AJPH.75.8.863","volume":"75","author":"RR Dodge","year":"1985","unstructured":"Dodge RR, Lebowitz MD, Barbee RA, et al. Estimates of C. immitis infection by skin test reactivity in an endemic community. Am J Public Health. 1985;75:863\u20135.","journal-title":"Am J Public Health"},{"key":"606_CR36","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/313724","volume":"30","author":"TR Larwood","year":"2000","unstructured":"Larwood TR. Coccidioidin skin testing in Kern County, California: decrease in infection rate over 58 years. Clin Infect Dis. 2000;30:612\u20133.","journal-title":"Clin Infect Dis"},{"key":"606_CR37","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1128\/JCM.42.10.4552-4555.2004","volume":"42","author":"NF Crum","year":"2004","unstructured":"Crum NF, Potter M, Pappagianis D. Seroincidence of coccidioidomycosis during military desert training exercises. J Clin Microbiol. 2004;42:4552\u20135.","journal-title":"J Clin Microbiol"},{"key":"606_CR38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3201\/eid1004.030446","volume":"10","author":"LR Petersen","year":"2004","unstructured":"Petersen LR, Marshall SL, Barton-Dickson C, et al. Coccidioidomycosis among workers at an archeological site, northeastern Utah. Emerg Infect Dis. 2004;10:637\u201342.","journal-title":"Emerg Infect Dis"},{"key":"606_CR39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3201\/eid2403.170623","volume":"24","author":"M Freedman","year":"2018","unstructured":"Freedman M, Jackson BR, McCotter O, Benedict K. Coccidioidomycosis outbreaks, United States and worldwide, 1940\u20132015. Emerg Infect Dis. 2018;24:417\u201323.","journal-title":"Emerg Infect Dis"},{"key":"606_CR40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/JOM.0b013e3182480556","volume":"54","author":"R Das","year":"2012","unstructured":"Das R, McNary J, Fitzsimmons K, et al. Occupational coccidioidomycosis in California: outbreak investigation, respirator recommendations, and surveillance findings. J Occup Environ Med. 2012;54:564\u201371.","journal-title":"J Occup Environ Med"},{"key":"606_CR41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1017\/S0950268809990999","volume":"138","author":"KC Cummings","year":"2010","unstructured":"Cummings KC, et al. Point-source outbreak of coccidioidomycosis in construction workers. Epidemiol Infect. 2010;138:507\u201311.","journal-title":"Epidemiol Infect"},{"key":"606_CR42","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3201\/eid2111.150129","volume":"21","author":"JA Wilken","year":"2015","unstructured":"Wilken JA, Sondermeyer G, Shusterman D, et al. Coccidioidomycosis among workers constructing solar power farms, California, USA, 2011\u20132014. Emerg Infect Dis. 2015;21:1997\u20132005.","journal-title":"Emerg Infect Dis"},{"key":"606_CR43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ajim.23218","volume":"64","author":"RL Laws","year":"2021","unstructured":"Laws RL, Jain S, Sondermeyer Cooksey G, et al. Coccidioidomycosis outbreak among inmate wildland firefighters: California, 2017. Am J Ind Med. 2021;64:266\u201373.","journal-title":"Am J Ind Med"},{"key":"606_CR44","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1196\/annals.1406.001","volume":"1111","author":"NF Crum-Cianflone","year":"2007","unstructured":"Crum-Cianflone NF. Coccidioidomycosis in the US Military: a review. Ann N Y Acad Sci. 2007;1111:112\u201321.","journal-title":"Ann N Y Acad Sci."},{"key":"606_CR45","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/infdis\/171.6.1672","volume":"171","author":"SM Standaert","year":"1995","unstructured":"Standaert SM, Schaffner W, Galgiani JN, et al. Coccidioidomycosis among visitors to a\u00a0Coccidioides immitis-endemic area: an outbreak in a military reserve unit. J Infect Dis. 1995;171:1672\u20135.","journal-title":"J Infect Dis."},{"key":"606_CR46","first-page":"1106","volume":"50","author":"Centers for Disease Control and Prevention (CDC)","year":"2001","unstructured":"Centers for Disease Control and Prevention (CDC). Public health dispatch: Coccidioidomycosis among persons attending the World Championship of Model Airplane Flying\u2014Kern County, California, October 2001. Morb Mort Wkly Rep. 2001;50:1106\u20137.","journal-title":"Morb Mort Wkly Rep."},{"key":"606_CR47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3201\/eid1602.090918","volume":"16","author":"NG Stern","year":"2010","unstructured":"Stern NG, Galgiani JN. Coccidioidomycosis among scholarship athletes and other college students, Arizona, USA. Emerg Infect Dis. 2010;16:321\u20133.","journal-title":"Emerg Infect Dis"},{"key":"606_CR48","doi-asserted-by":"crossref","unstructured":"Diaz JH. Travel-related risk factors for coccidioidomycosis. J Travel Med. 2018; 25(1).","DOI":"10.1093\/jtm\/tay027"},{"key":"606_CR49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1175\/WCAS-D-20-0036.1","volume":"13","author":"ME Gorris","year":"2021","unstructured":"Gorris ME, Neumann JE, Kinney PL, Sheahan M, Sarofim MC. Economic valuation of coccidioidomycosis (Valley Fever) projections in the United States in response to climate change. Weather Clim Soc. 2021;13:107\u201323.","journal-title":"Weather Clim Soc"},{"key":"606_CR50","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/jama.1997.03540350054033","volume":"277","author":"E Schneider","year":"1997","unstructured":"Schneider E, Hajjeh RA, Spiegel RA, et al. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA. 1997;277:904\u20138.","journal-title":"JAMA"},{"key":"606_CR51","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1056\/NEJM197908163010705","volume":"301","author":"NM Flynn","year":"1979","unstructured":"Flynn NM, Hoeprich PD, Kawachi MM, et al. An unusual outbreak of windborne coccidioidomycosis. N Engl J Med. 1979;301:358\u201361.","journal-title":"N Engl J Med."},{"key":"606_CR52","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1002\/2017GL073524","volume":"44","author":"DQ Tong","year":"2017","unstructured":"Tong DQ, Wang JXL, Gill TE, Lei H, Wang B. Intensified dust storm activity and valley fever infection in the southwestern United States. Geophys Res Lett. 2017;44:4304\u201312.","journal-title":"Geophys Res Lett"},{"key":"606_CR53","unstructured":"Lucas KD, Wheeler C, Mohle-Boetani JC. Coccidioidomycosis outbreaks among inmate wildland firefighters in California. In: Proceedings of the 63rd Coccidioidomycosis Study Group Annual Meeting; 2019 Apr 5\u20136. Sacramento, CA, USA."},{"key":"606_CR54","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s10393-018-1375-9","volume":"15","author":"EA Weaver","year":"2018","unstructured":"Weaver EA, Kolivras KN. Investigating the relationship between climate and valley fever (coccidioidomycosis). EcoHealth. 2018;15:840\u201352.","journal-title":"EcoHealth"},{"key":"606_CR55","doi-asserted-by":"crossref","first-page":"ofab020","DOI":"10.1093\/ofid\/ofab020","volume":"8","author":"K Benedict","year":"2021","unstructured":"Benedict K, Li Y, Molinari NAM, Jackson BR. Health care providers\u2019 testing practices for coccidioidomycosis and histoplasmosis in patients with community-acquired pneumonia-United States, 2020. Open Forum Infect Dis. 2021;8:ofab020.","journal-title":"Open Forum Infect Dis."},{"key":"606_CR56","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3201\/eid2404.161568","volume":"24","author":"SY Tartof","year":"2018","unstructured":"Tartof SY, Benedict K, Xie F, et al. Testing for coccidioidomycosis among community-acquired pneumonia patients, southern California, USA. Emerg Infect Dis. 2018;24:779\u201381.","journal-title":"Emerg Infect Dis"},{"key":"606_CR57","first-page":"233","volume":"79","author":"JW Wilson","year":"1953","unstructured":"Wilson JW, Smith CE, Plunkett OA. Primary cutaneous coccidioidomycosis; the criteria for diagnosis and a report of a case. Calif Med. 1953;79:233\u20139.","journal-title":"Calif Med"},{"key":"606_CR58","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1086\/378741","volume":"37","author":"PW Wright","year":"2003","unstructured":"Wright PW, Pappagianis D, Wilson M, et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis. 2003;37:1265\u20139.","journal-title":"Clin Infect Dis"},{"key":"606_CR59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1128\/CMR.00021-07","volume":"21","author":"P Mart\u00edn-D\u00e1vila","year":"2008","unstructured":"Mart\u00edn-D\u00e1vila P, Fort\u00fan J, L\u00f3pez-V\u00e9lez R. Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev. 2008;21:60\u201396.","journal-title":"Clin Microbiol Rev"},{"key":"606_CR60","doi-asserted-by":"crossref","first-page":"ofw086","DOI":"10.1093\/ofid\/ofw086","volume":"3","author":"JK Nelson","year":"2016","unstructured":"Nelson JK, Giraldeau G, Montoya JG, Deresinski S, Ho DY, Pham M. Donor-derived\u00a0Coccidioides immitis\u00a0endocarditis and disseminated infection in the setting of solid organ\u00a0transplantation. Open Forum Infect Dis. 2016;3:ofw086.","journal-title":"Open Forum Infect Dis."},{"key":"606_CR61","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00006454-199906000-00021","volume":"18","author":"V Charlton","year":"1999","unstructured":"Charlton V, Ramsdell K, Sehring S. Intrauterine transmission of coccidioidomycosis. Pediatr Infect Dis J. 1999;18:561\u20133.","journal-title":"Pediatr Infect Dis J"},{"key":"606_CR62","doi-asserted-by":"crossref","first-page":"e00112","DOI":"10.1128\/CMR.00112-19","volume":"33","author":"FM Donovan","year":"2019","unstructured":"Donovan FM, Shubitz L, Powell D, Orbach M, Frelinger J, Galgiani JN. Early events in coccidioidomycosis. Clin Microbiol Rev. 2019;33:e00112-e119.","journal-title":"Clin Microbiol Rev"},{"key":"606_CR63","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0002-9343(93)90054-S","volume":"94","author":"NM Ampel","year":"1993","unstructured":"Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med. 1993;94:235\u201340.","journal-title":"Am J Med"},{"key":"606_CR64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/j.1365-280X.1999.00227.x","volume":"37","author":"NM Ampel","year":"1999","unstructured":"Ampel NM. Delayed-type hypersensitivity, in vitro T-cell responsiveness and risk of active coccidioidomycosis among HIV-infected patients living in the coccidioidal endemic area. Med Mycol. 1999;37:245\u201350.","journal-title":"Med Mycol"},{"key":"606_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/648719","volume":"50","author":"FY Masannat","year":"2010","unstructured":"Masannat FY, Ampel NM. Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy. Clin Infect Dis. 2010;50:1\u20137.","journal-title":"Clin Infect Dis"},{"key":"606_CR66","unstructured":"Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America, available at: https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/Adult_OI.pdf. Accessed January 23, 2022."},{"key":"606_CR67","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/315401","volume":"181","author":"CW Woods","year":"2000","unstructured":"Woods CW, McRill C, Plikaytis BD, et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994\u20131997: incidence, risk factors, and prevention. J Infect Dis. 2000;181:1428\u201334.","journal-title":"J Infect Dis"},{"key":"606_CR68","first-page":"e11","volume":"119","author":"NF Crum","year":"2006","unstructured":"Crum NF, Ballon-Landa G. Coccidioidomycosis in pregnancy: case report and review of the literature. Am J Med. 2006;119:e11-17.","journal-title":"Am J Med"},{"key":"606_CR69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/cid\/cir410","volume":"53","author":"RS Bercovitch","year":"2011","unstructured":"Bercovitch RS, Catanzaro A, Schwartz BS, Pappagianis D, Watts DH, Ampel NM. Coccidioidomycosis during pregnancy: a review and recommendations for management. Clin Infect Dis. 2011;53:363\u20138.","journal-title":"Clin Infect Dis"},{"key":"606_CR70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jinf.2011.07.006","volume":"63","author":"CA Duplessis","year":"2011","unstructured":"Duplessis CA, Tilley D, Bavaro M, Hale B, Holland SM. Two cases illustrating successful adjunctive interferon-gamma immunotherapy in refractory disseminated coccidioidomycosis. J Infect. 2011;63:223\u20138.","journal-title":"J Infect"},{"key":"606_CR71","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jaci.2013.01.052","volume":"131","author":"EP Sampaio","year":"2013","unstructured":"Sampaio EP, Hsu AP, Pechacek J, et al. Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis. J Allergy Clin Immunol. 2013;131:1624\u201334.","journal-title":"J Allergy Clin Immunol"},{"key":"606_CR72","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/INF.0b013e31819866ec","volume":"28","author":"AE Powers","year":"2009","unstructured":"Powers AE, Bender JM, Kumanovics A, et al. Coccidioides immitis meningitis in a patient with hyperimmunoglobulin E syndrome due to a novel mutation in signal transducer and activator of transcription. Pediatr Infect Dis J. 2009;28:664\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"606_CR73","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1086\/605532","volume":"49","author":"DC Vinh","year":"2009","unstructured":"Vinh DC, Masannat F, Dzioba RB, Galgiani JN, Holland SM. Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency. Clin Infect Dis. 2009;49:e62\u20135.","journal-title":"Clin Infect Dis"},{"key":"606_CR74","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1093\/cid\/ciq215","volume":"52","author":"DC Vinh","year":"2011","unstructured":"Vinh DC, Schwartz B, Hsu AP, et al. Interleukin-12 receptor beta1 deficiency predisposing to disseminated coccidioidomycosis. Clin Infect Dis. 2011;52:e99-102.","journal-title":"Clin Infect Dis"},{"key":"606_CR75","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.amjmed.2006.03.033","volume":"119","author":"AC Santelli","year":"2006","unstructured":"Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med. 2006;119:964\u20139.","journal-title":"Am J Med"},{"key":"606_CR76","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.md.0000126762.91040.fd","volume":"83","author":"NF Crum","year":"2004","unstructured":"Crum NF, Lederman ER, Stafford CM, Parrish JS, Wallace MR. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Med (Baltim). 2004;83:149\u201375.","journal-title":"Med (Baltim)."},{"key":"606_CR77","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3201\/eid1809.120151","volume":"18","author":"AE Seitz","year":"2012","unstructured":"Seitz AE, Prevots DR, Holland SM. Hospitalizations associated with disseminated coccidioidomycosis, Arizona and California, USA. Emerg Infect Dis. 2012;18:1476\u20139.","journal-title":"Emerg Infect Dis"},{"key":"606_CR78","doi-asserted-by":"crossref","first-page":"ofz052","DOI":"10.1093\/ofid\/ofz052","volume":"6","author":"O McCotter","year":"2019","unstructured":"McCotter O, Kennedy J, McCollum J, et al. Coccidioidomycosis among American Indians and Alaska Natives 2001\u20132014. Open Forum Infect Dis. 2019;6:ofz052.","journal-title":"Open Forum Infect Dis."},{"key":"606_CR79","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3201\/eid1811.120752","volume":"18","author":"JY Huang","year":"2012","unstructured":"Huang JY, Bristow B, Shafir S, Sorvillo F. Coccidioidomycosis-associated deaths, United States, 1990\u20132008. Emerg Infect Dis. 2012;18:1723\u20138.","journal-title":"Emerg Infect Dis"},{"key":"606_CR80","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","volume":"63","author":"JN Galgiani","year":"2016","unstructured":"Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of Coccidioidomycosis. Clin Infect Dis. 2016;63:e112\u201346.","journal-title":"Clin Infect Dis"},{"key":"606_CR81","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3201\/eid1206.060028","volume":"12","author":"L Valdivia","year":"2006","unstructured":"Valdivia L, Nix D, Wright M, Lindberg E, Fagan T, Lieberman D, et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis. 2006;12:958\u201362.","journal-title":"Emerg Infect Dis"},{"key":"606_CR82","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3201\/eid1563.081007","volume":"15","author":"MM Kim","year":"2009","unstructured":"Kim MM, Blair JE, Carey EJ, Wu Q, Smilack JD. Coccidioidal pneumonia, Phoenix, Arizona, USA, 2000\u20132004. Emerg Infect Dis. 2009;15:397\u2013401.","journal-title":"Emerg Infect Dis"},{"key":"606_CR83","doi-asserted-by":"crossref","first-page":"e4336","DOI":"10.1093\/cid\/ciaa1554","volume":"73","author":"K Benedict","year":"2021","unstructured":"Benedict K, Kobayashi M, Garg S, Chiller T, Jackson BR. Symptoms in blastomycosis, coccidioidomycosis, and histoplasmosis versus other respiratory illnesses in commercially insured adult outpatients-United States, 2016\u20132017. Clin Infect Dis. 2021;73:e4336\u201344.","journal-title":"Clin Infect Dis"},{"key":"606_CR84","doi-asserted-by":"crossref","first-page":"ofv086","DOI":"10.1093\/ofid\/ofv086","volume":"2","author":"LM Horng","year":"2015","unstructured":"Horng LM, Yaghoubian S, Ram A, et al. Endocarditis due to Coccidioides spp: the seventh case. Open Forum Infect Dis. 2015;2:ofv086.","journal-title":"Open Forum Infect Dis."},{"key":"606_CR85","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.SMJ.0000110406.39845.D8","volume":"97","author":"AA Truett","year":"2004","unstructured":"Truett AA, Crum NF. Coccidioidomycosis of the prostate gland: two cases and a review of the literature. South Med J. 2004;97:419\u201322.","journal-title":"South Med J"},{"key":"606_CR86","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1086\/313808","volume":"30","author":"P Phillips","year":"2000","unstructured":"Phillips P, Ford B. Peritoneal coccidioidomycosis: case report and review. Clin Infect Dis. 2000;30:971\u20136.","journal-title":"Clin Infect Dis"},{"key":"606_CR87","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/archopht.116.5.674","volume":"116","author":"ET Cunningham Jr","year":"1998","unstructured":"Cunningham ET Jr, Seiff SR, Berger TG, et al. Intraocular coccidioidomycosis diagnosed by skin biopsy. Arch Ophthalmol. 1998;116:674\u20137.","journal-title":"Arch Ophthalmol"},{"key":"606_CR88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archinte.158.1.89","volume":"158","author":"JD Smilack","year":"1998","unstructured":"Smilack JD, Argueta R. Coccidioidal infection of the thyroid. Arch Intern Med. 1998;158:89\u201392.","journal-title":"Arch Intern Med"},{"key":"606_CR89","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3201\/eid2407.172063","volume":"24","author":"EM Brown","year":"2018","unstructured":"Brown EM, McTaggart LR, Dunn D, et al. Epidemiology and geographic distribution of blastomycosis, histoplasmosis, and coccidioidomycosis, Ontario, Canada, 1990\u20132015. Emerg Infect Dis. 2018;24:1257\u201366.","journal-title":"Emerg Infect Dis"},{"key":"606_CR90","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1086\/516970","volume":"25","author":"A Ogiso","year":"1997","unstructured":"Ogiso A, Ito M, Koyama M, Yamaoka H, Hotchi M, McGinnis MR. Pulmonary coccidioidomycosis in Japan: case report and review. Clin Infect Dis. 1997;25:1260\u20131.","journal-title":"Clin Infect Dis"},{"key":"606_CR91","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3346\/jkms.1999.14.2.206","volume":"14","author":"J Jang","year":"1999","unstructured":"Jang J, Lee HJ, Lee I, Cho YK, Kim HJ, Sohn KH. The first imported case of pulmonary coccidioidomycosis in Korea. J Korean Med Sci. 1999;14:206\u20139.","journal-title":"J Korean Med Sci"},{"key":"606_CR92","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.medmal.2007.08.004","volume":"38","author":"MO Chandesris","year":"2008","unstructured":"Chandesris MO, et al. Coccidioidomycosis: an imported invasive fungal disease in France. Med Mal Infect. 2008;38:336\u201342.","journal-title":"Med Mal Infect"},{"issue":"50","key":"606_CR93","first-page":"pii=2074","volume":"5","author":"N Asgari","year":"2001","unstructured":"Asgari N, Hahn\u00e9 S, Heiskanen-Kosma T, Heli Siikam\u00e4ki, Morgan M. . Cases of coccidioidomycosis in Europe due to exposure in California, United States. Euro Surveill. 2001;5(50):pii=2074.","journal-title":"Euro Surveill."},{"key":"606_CR94","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s15010-012-0315-9","volume":"40","author":"JK Oberoi","year":"2012","unstructured":"Oberoi JK, Wattal C, Aggarwal PK, Khanna S, Basu AK, Verma K. Pulmonary coccidioidomycosis in New Delhi. India. Infection. 2012;40:699\u2013702.","journal-title":"Infection"},{"key":"606_CR95","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jtm\/tay053","volume":"25","author":"RJ Stoney","year":"2018","unstructured":"Stoney RJ, Esposito DH, Kozarsky P, et al. Infectious diseases acquired by international travellers visiting the USA. J Travel Med. 2018;25:10.","journal-title":"J Travel Med"},{"key":"606_CR96","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1378\/chest.12-1312","volume":"143","author":"GR Thompson","year":"2013","unstructured":"Thompson GR, Sharma S, Bays DJ. Coccidioidomycosis: Adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid. Chest. 2013;143:776\u201381.","journal-title":"Chest"},{"key":"606_CR97","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1513\/AnnalsATS.201404-180BC","volume":"11","author":"KK Sakata","year":"2014","unstructured":"Sakata KK, Grys TE, Chang YH, Vikram HR, Blair JE. Serum procalcitonin levels in patients with primary pulmonary coccidioidomycosis. Ann Am Thorac Soc. 2014;11:1239\u201343.","journal-title":"Ann Am Thorac Soc"},{"key":"606_CR98","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/cis536","volume":"55","author":"J Fierer","year":"2012","unstructured":"Fierer J, Burton DW, Haghighi P, et al. Hypercalcemia in disseminated coccidioidomycosis: expression of parathyroid hormone-related peptide is characteristic of granulomatous inflammation. Clin Infect Dis. 2012;55:e61\u20136.","journal-title":"Clin Infect Dis"},{"key":"606_CR99","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1128\/JCM.00631-12","volume":"50","author":"GR Thompson","year":"2012","unstructured":"Thompson GR, Bays DJ, Johnson SM, Cohen SH, Pappagianis D, Finkelmanc MA. Serum (1\u21923)-\u03b2-d-glucan measurement in coccidioidomycosis. J Clin Microbiol. 2012;50:3060\u20132.","journal-title":"J Clin Microbiol"},{"key":"606_CR100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11046-008-9129-9","volume":"166","author":"JE Blair","year":"2008","unstructured":"Blair JE, Currier JT. Significance of isolated positive IgM serologic results by enzyme immunoassay for coccidioidomycosis. Mycopathologia. 2008;166:77\u201382.","journal-title":"Mycopathologia"},{"key":"606_CR101","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1055\/s-0031-1295723","volume":"32","author":"GR Thompson","year":"2011","unstructured":"Thompson GR. Pulmonary Coccidioidomycosis. Semin Respir Crit Care Med. 2011;32:754\u201363.","journal-title":"Semin Respir Crit Care Med"},{"key":"606_CR102","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.3.3.247","volume":"3","author":"D Pappagianis","year":"1990","unstructured":"Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev. 1990;3:247\u201368.","journal-title":"Clin Microbiol Rev"},{"key":"606_CR103","doi-asserted-by":"crossref","first-page":"e2746","DOI":"10.1093\/cid\/ciaa1205","volume":"73","author":"FM Donovan","year":"2021","unstructured":"Donovan FM, Ramadan FA, Khan SA, et al. Comparison of a novel rapid lateral flow assay to enzyme immunoassay results for early diagnosis of Coccidioidomycosis. Clin Infect Dis. 2021;73:e2746\u201353.","journal-title":"Clin Infect Dis"},{"key":"606_CR104","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/jof5030054","volume":"5","author":"NR Jackson","year":"2019","unstructured":"Jackson NR, Blair JE, Ampel NM. Central nervous system infections due to coccidioidomycosis. J Fungi (Basel). 2019;5:54.","journal-title":"J Fungi (Basel)"},{"key":"606_CR105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/JCM.01776-06","volume":"45","author":"MJ Binnicker","year":"2007","unstructured":"Binnicker MJ, Buckwalter SP, Eisberner JJ, et al. Detection of Coccidioides species in clinical specimens by real-time PCR. J Clin Microbiol. 2007;45:173\u20138.","journal-title":"J Clin Microbiol"},{"key":"606_CR106","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11046-010-9327-0","volume":"170","author":"D Vucicevic","year":"2010","unstructured":"Vucicevic D, Blair JE, Binnicker MJ, et al. The utility of Coccidioides polymerase chain reaction testing in the clinical setting. Mycopathologia. 2010;170:345\u201351.","journal-title":"Mycopathologia"},{"key":"606_CR107","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-205333","author":"C Langelier","year":"2014","unstructured":"Langelier C, Baxi DM, Iribarne D, Chin-Hong P. Beyond the superficial:\u00a0Coccidioides immitis\u00a0fungaemia in a man with fever, fatigue and skin nodules: a case of an emerging and evolving pathogen. BMJ Case Rep. 2014. https:\/\/doi.org\/10.1136\/bcr-2014-205333.","journal-title":"BMJ Case Rep"},{"key":"606_CR108","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1128\/jcm.32.4.867-870.1994","volume":"32","author":"AA Padhye","year":"1994","unstructured":"Padhye AA, Smith G, McLaughlin D, Standard PG, Kaufman L. Comparative evaluation of a chemiluminescent DNA probe and an exoantigen tests for rapid identification of Blastomyces dermatitidis and Coccidioides immitis. J Clin Microbiol. 1994;32:867\u201370.","journal-title":"J Clin Microbiol"},{"key":"606_CR109","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cid\/civ388","volume":"61","author":"EE Wack","year":"2015","unstructured":"Wack EE, Ampel NM, Sunenshine RH, Galgiani JN. The return of delayed-type hypersensitivity skin testing for coccidioidomycosis. Clin Infect Dis. 2015;61:787\u201391.","journal-title":"Clin Infect Dis"},{"key":"606_CR110","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1093\/mmy\/myy029","volume":"57","author":"JR Thompson","year":"2019","unstructured":"Thompson JR, Lewis JS, Nix DE, Patterson TF. Current concepts and future directions in the pharmacology and treatment of coccidioidomycosis. Med Mycol. 2019;57:S76\u201384.","journal-title":"Med Mycol"},{"key":"606_CR111","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1128\/AAC.48.6.2140-2143.2004","volume":"48","author":"GM Gonz\u00e1lez","year":"2004","unstructured":"Gonz\u00e1lez GM, Tijerina R, Najvar LK, Bocanegra R, Rinaldi MG, Graybill JR. Efficacies of Amphotericin B (AMB) Lipid Complex, AMB Colloidal Dispersion, Liposomal AMB, and Conventional AMB in treatment of murine coccidioidomycosis. Antimicrob Agents Chemother. 2004;48:2140\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"606_CR112","doi-asserted-by":"crossref","first-page":"e02293","DOI":"10.1128\/AAC.02293-17","volume":"62","author":"R Sidhu","year":"2018","unstructured":"Sidhu R, Lash DB, Heidari A, Natarajan P, Johnson RH. Evaluation of amphotericin b lipid formulations for treatment of severe coccidioidomycosis. Antimicrob Agents Chemother. 2018;62:e02293-e2317.","journal-title":"Antimicrob Agents Chemother"},{"key":"606_CR113","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/srin.2001.29298","volume":"16","author":"DA Stevens","year":"2001","unstructured":"Stevens DA, Shatsky SA. Intrathecal amphotericin in the management of coccidioidal meningitis. Semin Respir Infect. 2001;16:263\u20139.","journal-title":"Semin Respir Infect"},{"key":"606_CR114","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1128\/AAC.00963-13","volume":"57","author":"ES Zhu","year":"2013","unstructured":"Zhu ES, Thompson GR, Kreulen C, Giza E. Amphotericin B-impregnated bone cement to treat refractory coccidioidal osteomyelitis. Antimicrob Agents Chemother. 2013;57:6341\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"606_CR115","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/0003-4819-133-9-200011070-00009","volume":"133","author":"JN Galgiani","year":"2000","unstructured":"Galgiani JN, Catanzaro A, Cloud GA, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial Mycoses Study. Group Ann Intern Med. 2000;133:676\u201386.","journal-title":"Group Ann Intern Med"},{"key":"606_CR116","doi-asserted-by":"crossref","first-page":"E179","DOI":"10.1503\/cmaj.180963","volume":"191","author":"A B\u00e9rard","year":"2019","unstructured":"B\u00e9rard A, Sheehy O, Zhao J-P, Gorgui J, Bernatsky S, Soares de Moura C, Abrahamowicz M. Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies. CMAJ. 2019;191:E179-87.","journal-title":"CMAJ."},{"key":"606_CR117","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1301066","volume":"369","author":"D Molgaard-Nielsen","year":"2013","unstructured":"Molgaard-Nielsen D, Pasternak B, Hviid A. Use of oral fluconazole during pregnancy and the risk of birth defects. N Engl J Med. 2013;369:830\u20139.","journal-title":"N Engl J Med"},{"key":"606_CR118","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/myc.12749","volume":"61","author":"WJ Hoffmann","year":"2018","unstructured":"Hoffmann WJ, McHardy I, Thompson GR 3rd. Itraconazole induced hypertension and hypokalemia: mechanistic evaluation. Mycoses. 2018;61:337\u20139.","journal-title":"Mycoses"},{"key":"606_CR119","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.2012.11196.x","volume":"168","author":"AK Haylett","year":"2013","unstructured":"Haylett AK, Felton S, Denning DW, Rhodes LE. Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients. Br J Dermatol. 2013;168:179\u201385.","journal-title":"Br J Dermatol"},{"key":"606_CR120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","volume":"46","author":"A Pascual","year":"2008","unstructured":"Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis. 2008;46:201\u201311.","journal-title":"Clin Infect Dis"},{"key":"606_CR121","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/cid\/cir642","volume":"53","author":"MM Kim","year":"2011","unstructured":"Kim MM, Vikram HR, Kusne S, Seville MT, Blair JE. Treatment of refractory coccidioidomycosis with voriconazole or posaconazole. Clin Infect Dis. 2011;53:1060\u20136.","journal-title":"Clin Infect Dis"},{"key":"606_CR122","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1128\/AAC.01148-07","volume":"53","author":"A Freifeld","year":"2009","unstructured":"Freifeld A, Proia L, Andes D, et al. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother. 2009;53:1648\u201351.","journal-title":"Antimicrob Agents Chemother"},{"key":"606_CR123","first-page":"e00835","volume":"21","author":"A De la Hoz","year":"2020","unstructured":"De la Hoz A, Malek A, Hasbun R. Interferon-\u03b3 and voriconazole combined therapy for refractory meningeal coccidioidomycosis in a patient with interferon-\u03b3 deficiency. ID Cases. 2020;21:e00835.","journal-title":"ID Cases."},{"key":"606_CR124","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1086\/375235","volume":"36","author":"KJ Cortez","year":"2003","unstructured":"Cortez KJ, Walsh TJ, Bennett JE. Successful treatment of coccidioidal meningitis with voriconazole. Clin Infect Dis. 2003;36:1619\u201322.","journal-title":"Clin Infect Dis"},{"key":"606_CR125","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1210\/js.2019-00189","volume":"3","author":"GR Thompson","year":"2019","unstructured":"Thompson GR, Beck KR, Patt M, Kratschmar DV, Odermatt A. Posaconazole-induced hypertension due to inhibition of 11 \u03b2-Hydroxylase and 11 \u03b2-Hydroxysteroid dehydrogenase 2. J Endocr Soc. 2019;3:1361\u20136.","journal-title":"J Endocr Soc"},{"key":"606_CR126","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/jac\/dkn409","volume":"62","author":"MJ R\u00fcping","year":"2008","unstructured":"R\u00fcping MJ, Albermann N, Ebinger F, et al. Posaconazole concentrations in the central nervous system. J Antimicrob Chemother. 2008;62:1468\u201370.","journal-title":"J Antimicrob Chemother"},{"key":"606_CR127","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/519937","volume":"45","author":"A Catanzaro","year":"2007","unstructured":"Catanzaro A, Cloud GA, Stevens DA, Levine BE, Williams PL, Johnson RH. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis. Clin Infect Dis. 2007;45:562\u20138.","journal-title":"Clin Infect Dis"},{"key":"606_CR128","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1086\/430303","volume":"40","author":"GM Anstead","year":"2005","unstructured":"Anstead GM, Corcoran G, Lewis J, Berg D, Graybill JR. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis. 2005;40:1770\u20136.","journal-title":"Clin Infect Dis"},{"key":"606_CR129","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/cid\/cir734","volume":"53","author":"R Schein","year":"2011","unstructured":"Schein R, Homans J, Larsen RA, Neely M. Posaconazole for chronic refractory coccidioidal meningitis. Clin Infect Dis. 2011;53:1252\u20134.","journal-title":"Clin Infect Dis"},{"key":"606_CR130","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/INF.0000000000003017","volume":"40","author":"F Naeem","year":"2021","unstructured":"Naeem F, Laningham F, Kuzmic B, Clerkin P, McCarty J. Isavuconazole as salvage therapy for refractory pediatric coccidioidal meningitis. Pediatr Infect Dis J. 2021;40:e128\u201331.","journal-title":"Pediatr Infect Dis J"},{"key":"606_CR131","doi-asserted-by":"crossref","first-page":"e02232","DOI":"10.1128\/AAC.02232-18","volume":"63","author":"A Heidari","year":"2019","unstructured":"Heidari A, Quinlan M, Benjamin DJ, Laurence B, Mu A, Ngai T, et al. Isavuconazole in the treatment of coccidioidal meningitis. Antimicrob Agents Chemother. 2019;63:e02232-e2318.","journal-title":"Antimicrob Agents Chemother"},{"key":"606_CR132","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cid\/ciw305","volume":"63","author":"GR Thompson","year":"2016","unstructured":"Thompson GR, Rendon A, Ribeiro Dos Santos R, et al. Isavuconazole treatment of cryptococcosis and dimorphic mycoses. Clin Infect Dis. 2016;63:356\u201362.","journal-title":"Clin Infect Dis."},{"key":"606_CR133","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/mmy\/myab035","volume":"59","author":"MR Davis","year":"2021","unstructured":"Davis MR, Chang S, Gaynor P, McCreary EK, Allyn P. Isavuconazole for treatment of refractory coccidioidal meningitis with concomitant cerebrospinal fluid and plasma therapeutic drug monitoring. Med Mycol. 2021;59:939\u201342.","journal-title":"Med Mycol"},{"key":"606_CR134","doi-asserted-by":"crossref","first-page":"e02634-16","DOI":"10.1128\/AAC.02634-16","volume":"61","author":"GR Thompson","year":"2017","unstructured":"Thompson GR, Barker BM, Wiederhold NP. Large-scale evaluation of in vitro amphotericin b, triazole, and echinocandin activity against Coccidioides species from US institutions. Antimicrob Agents Chemother. 2017;61:e02634-16.","journal-title":"Antimicrob Agents Chemother."},{"key":"606_CR135","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1128\/AAC.47.4.1376-1381.2003","volume":"47","author":"T Nakai","year":"2003","unstructured":"Nakai T, Uno J, Ikeda F, Tawara S, Nishimura K, Miyaji M. In vitro antifungal activity of micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms. Antimicrob Agents Chemother. 2003;47:1376\u201381.","journal-title":"Antimicrob Agents Chemother"},{"key":"606_CR136","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1128\/AAC.45.6.1854-1859.2001","volume":"45","author":"GM Gonzalez","year":"2001","unstructured":"Gonzalez GM, Tijerina R, Najvar LK, Bocanegra R, Luther M, Rinaldi MG, Graybill JR. Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model. Antimicrob Agents Chemother. 2001;45:1854\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"606_CR137","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/jac\/dkm383","volume":"60","author":"GM Gonz\u00e1lez","year":"2007","unstructured":"Gonz\u00e1lez GM, Gonz\u00e1lez G, Najvar LK, Graybill JR. Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model. J Antimicrob Chemother. 2007;60:1341\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"606_CR138","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab904","author":"E O'Shaughnessy","year":"2021","unstructured":"O\u2019Shaughnessy E, Yasinskaya Y, Dixon C, et al. FDA public workshop summary-coccidioidomycosis (valley fever): Considerations for development of antifungal drugs. Clin Infect Dis. 2021. https:\/\/doi.org\/10.1093\/cid\/ciab904.","journal-title":"Clin Infect Dis"},{"key":"606_CR139","first-page":"e00400","volume":"64","author":"GR Thompson 3rd","year":"2020","unstructured":"Thompson GR 3rd, Lewis P, Mudge S, Patterson TF, Burnett BP. Open-label crossover oral bioequivalence pharmacokinetics comparison for a 3-day loading dose regimen and 15-day steady-state administration of SUBA-itraconazole and conventional itraconazole capsules in healthy adults. Antimicrob Agents Chemother. 2020;64:e00400-e420.","journal-title":"Antimicrob Agents Chemother"},{"key":"606_CR140","doi-asserted-by":"crossref","first-page":"e01450","DOI":"10.1128\/AAC.01450-20","volume":"64","author":"P Hnik","year":"2020","unstructured":"Hnik P, Wasan EK, Wasan KM. Safety, Tolerability, and Pharmacokinetics of a novel oral amphotericin b formulation (iCo-019) following single-dose administration to healthy human subjects: an alternative approach to parenteral amphotericin b administration. Antimicrob Agents Chemother. 2020;64:e01450-e1520.","journal-title":"Antimicrob Agents Chemother"},{"key":"606_CR141","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/jof6030122","volume":"6","author":"NP Wiederhold","year":"2020","unstructured":"Wiederhold NP. Review of the novel investigational antifungal olorofim. J Fungi. 2020;6:122.","journal-title":"J Fungi"},{"key":"606_CR142","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00999-18","author":"NP Wiederhold","year":"2018","unstructured":"Wiederhold NP, Najvar LK, Jaramillo R, et al. The orotomide Olorofim is efficacious in an experimental model of central nervous system coccidioidomycosis. Antimicrob Agents Chemother. 2018. https:\/\/doi.org\/10.1128\/AAC.00999-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"606_CR143","doi-asserted-by":"crossref","first-page":"e0028521","DOI":"10.1128\/AAC.00285-21","volume":"65","author":"G Sass","year":"2021","unstructured":"Sass G, Larwood DJ, Martinez M, Chatterjee P, Xavier MO, Stevens DA. Nikkomycin Z against disseminated coccidioidomycosis in a murine model of sustained-release dosing. Antimicrob Agents Chemother. 2021;65:e0028521.","journal-title":"Antimicrob Agents Chemother"},{"key":"606_CR144","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3109\/13693786.2013.770610","volume":"51","author":"LF Shubitz","year":"2013","unstructured":"Shubitz LF, Roy ME, Nix DE, Galgiani JN. Efficacy of Nikkomycin Z for respiratory coccidioidomycosis in naturally infected dogs. Med Mycol. 2013;51:747\u201354.","journal-title":"Med Mycol"},{"key":"606_CR145","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/infdis\/jiu029","volume":"209","author":"LF Shubitz","year":"2014","unstructured":"Shubitz LF, Trinh HT, Perrill RH, et al. Modeling Nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials. J Infect Dis. 2014;209:1949\u201354.","journal-title":"J Infect Dis"},{"issue":"1","key":"606_CR146","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/jof6010028","volume":"6","author":"TJ Gintjee","year":"2020","unstructured":"Gintjee TJ, Donnelley MA, Thompson GR. Aspiring antifungals: Review of current antifungal pipeline developments. J Fungi (Basel). 2020;6(1):28.","journal-title":"J Fungi (Basel)"},{"key":"606_CR147","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/cid\/cit113","volume":"56","author":"ER Levy","year":"2013","unstructured":"Levy ER, McCarty JM, Shane AL, Weintrub PS. Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series. Clin Infect Dis. 2013;56:1573\u20138.","journal-title":"Clin Infect Dis"},{"key":"606_CR148","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1128\/AAC.43.6.1401","volume":"43","author":"RK Li","year":"1999","unstructured":"Li RK, Rinaldi MG. In vitro antifungal activity of Nikkomycin Z in combination with fluconazole or itraconazole. Antimicrob Agents Chemother. 1999;43:1401\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"606_CR149","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/595687","volume":"48","author":"NM Ampel","year":"2009","unstructured":"Ampel NM, Giblin A, Mourani JP, Galgiani JN. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis. Clin Infect Dis. 2009;48:172\u20138.","journal-title":"Clin Infect Dis"},{"key":"606_CR150","first-page":"983","volume":"20","author":"JE Blair","year":"2014","unstructured":"Blair JE, Chang YH, Cheng MR, et al. Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosis. Emerg Infect Dis. 2014;20:983\u201390.","journal-title":"Emerg Infect Dis"},{"key":"606_CR151","doi-asserted-by":"crossref","first-page":"100851","DOI":"10.1016\/j.conctc.2021.100851","volume":"24","author":"JA Messina","year":"2021","unstructured":"Messina JA, Maziarz EK, Galgiani J. A randomized, double-blind, placebo-controlled clinical trial of fluconazole as early empiric treatment of coccidioidomycosis pneumonia (Valley Fever) in adults presenting with community-acquired pneumonia in endemic areas (FLEET-Valley Fever). Contemp Clin Trials Commun. 2021;24:100851.","journal-title":"Contemp Clin Trials Commun."},{"key":"606_CR152","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1093\/cid\/cir466","volume":"53","author":"GR Thompson","year":"2011","unstructured":"Thompson GR, Lunetta JM, Johnson SM, et al. Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis. Clin Infect Dis. 2011;53:e20\u20134.","journal-title":"Clin Infect Dis"},{"key":"606_CR153","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/clinids\/20.5.1281","volume":"20","author":"HL Arguinchona","year":"1995","unstructured":"Arguinchona HL, Ampel NM, Dols CL, Galgiani JN, Mohler MJ, Fish DG. Persistent coccidioidal seropositivity without clinical evidence of active coccidioidomycosis in patients infected with human immunodeficiency virus. Clin Infect Dis. 1995;20:1281\u20135.","journal-title":"Clin Infect Dis"},{"key":"606_CR154","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1086\/382075","volume":"38","author":"TT Kuberski","year":"2004","unstructured":"Kuberski TT, Servi RJ, Rubin PJ. Successful treatment of a critically ill patient with disseminated coccidioidomycosis, using adjunctive interferon-gamma. Clin Infect Dis. 2004;38:910\u20132.","journal-title":"Clin Infect Dis"},{"key":"606_CR155","doi-asserted-by":"crossref","first-page":"e01318-18","DOI":"10.1128\/JCM.01318-18","volume":"56","author":"IH McHardy","year":"2018","unstructured":"McHardy IH, Dinh B-TN, Waldman S, et al. Coccidioidomycosis complement fixation titer trends in the age of antifungals. J Clin Microbiol. 2018;56:e01318-18.","journal-title":"J Clin Microbiol."},{"key":"606_CR156","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3201\/eid1611.100475","volume":"16","author":"CA Tsang","year":"2010","unstructured":"Tsang CA, Anderson SM, Imholte SB, et al. Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007\u20132008. Emerg Infect Dis. 2010;16:1738\u201344.","journal-title":"Emerg Infect Dis"},{"key":"606_CR157","doi-asserted-by":"crossref","first-page":"ofaa623","DOI":"10.1093\/ofid\/ofaa623","volume":"8","author":"AJ Grizzle","year":"2020","unstructured":"Grizzle AJ, Wilson L, Nix DE, Galgiani JN. Clinical and economic burden of valley fever in arizona: an incidence-based cost-of-illness analysis. Open Forum Infect Dis. 2020;8:ofaa623.","journal-title":"Open Forum Infect Dis."},{"key":"606_CR158","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3201\/eid2705.204661","volume":"27","author":"AK Heaney","year":"2021","unstructured":"Heaney AK, Head JR, Broen K, et al. Coccidioidomycosis and COVID-19 co-infection, United States, 2020. Emerg Infect Dis. 2021;27:1266\u201373.","journal-title":"Emerg Infect Dis"},{"key":"606_CR159","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/jof7070556","volume":"7","author":"MG Fr\u00edas-De-Le\u00f3n","year":"2021","unstructured":"Fr\u00edas-De-Le\u00f3n MG, Pinto-Almaz\u00e1n F, Hern\u00e1ndez-Castro R, et al. Epidemiology of mycoses in the COVID-19 pandemic. J Fungi (Basel). 2021;7:556.","journal-title":"J Fungi (Basel)"},{"key":"606_CR160","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/milmed\/usab132","volume":"186","author":"DS Krauth","year":"2021","unstructured":"Krauth DS, Jamros CM, Rivard SC, Olson NH, Maves RC. Accelerated progression of disseminated coccidioidomycosis following SARS-CoV-2 infection: a case report. Mil Med. 2021;186:1254\u20136.","journal-title":"Mil Med"},{"key":"606_CR161","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab752","author":"CN Truong","year":"2021","unstructured":"Truong CN, Nailor MD, Walia R, Cherrier L, Nasar A, Goodlet KJ. Universal lifelong fungal prophylaxis and risk of coccidioidomycosis in lung transplant recipients living in an endemic area. Clin Infect Dis. 2021. https:\/\/doi.org\/10.1093\/cid\/ciab752.","journal-title":"Clin Infect Dis."},{"key":"606_CR162","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1086\/605441","volume":"49","author":"DA Stevens","year":"2009","unstructured":"Stevens DA, Clemons KV, Levine HB, et al. Expert opinion: what to do when there is Coccidioides exposure in a laboratory. Clin Infect Dis. 2009;49:919\u201323.","journal-title":"Clin Infect Dis"},{"key":"606_CR163","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.3390\/jof2040034","volume":"2","author":"TN Kirkland","year":"2016","unstructured":"Kirkland TN. The quest for a vaccine against coccidioidomycosis: a neglected disease of the Americas. J Fungi (Basel). 2016;2:E34.","journal-title":"J Fungi (Basel)"},{"key":"606_CR164","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.2164-0947.1960.tb00711.x","volume":"22","author":"HB Levine","year":"1960","unstructured":"Levine HB, Cobb JM, Smith CE. Immunity to coccidioidomycosis induced in mice by purified spherule, arthrospore, and mycelial vaccines. Trans N Y Acad Sci. 1960;22:436\u201349.","journal-title":"Trans N Y Acad Sci"},{"key":"606_CR165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/br.31.1.35-53.1967","volume":"31","author":"YC Kong","year":"1967","unstructured":"Kong YC, Levine HB. Experimentally induced immunity in the mycoses. Bacteriol Rev. 1967;31:35\u201353.","journal-title":"Bacteriol Rev"},{"key":"606_CR166","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1164\/ajrccm\/148.3.656","volume":"148","author":"D Pappagianis","year":"1993","unstructured":"Pappagianis D. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group. Am Rev Respir Dis. 1993;148:656\u201360.","journal-title":"Am Rev Respir Dis."},{"key":"606_CR167","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/jof6040354","volume":"6","author":"NM Ampel","year":"2020","unstructured":"Ampel NM. Coccidioidomycosis: changing concepts and knowledge gaps. J Fungi (Basel). 2020;6:354.","journal-title":"J Fungi (Basel)"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00606-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-022-00606-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00606-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T15:38:02Z","timestamp":1648481882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-022-00606-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":167,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1007\/s40121-022-00606-y","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}